Rapti Madurawe, PhD

FDA/CDER/OPQ
Director, Division of Process Assessment I
Rapti Madurawe is a Division Director in the Office of Process and Facilities, Office of Pharmaceutical Quality, FDA. She has extensive regulatory experience in the CMC assessment of new, investigational drug and generic drug applications. Prior to joining the FDA, Rapti worked in biotech and biopharmaceutical companies and has industry experience in process development, process scale up and manufacturing tech support. Rapti has a Ph.D. in Chemical Engineering from Virginia Tech, USA and a Master’s degree in Biochemistry from the University of Kentucky, USA.